Jing W Li

US Patent:

20030032027, Feb 13, 2003

Filed:

Feb 12, 2002

Appl. No.:

10/073123

Inventors:

Jing Li - Flushing NY, US
Scott Powers - Greenlawn NY, US

International Classification:

C12Q001/68
G06F019/00
A61K048/00

US Classification:

435/006000, 702/020000, 514/044000

Abstract:

There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing the WIP1 gene, which are amplified breast, and/or lung, and/or colon, and/or ovarian, and/or prostate cancer genes. The WIP1 gene, its expressed protein products and antibodies are used diagnostically or as targets for cancer therapy; they are also used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy.

US Patent:

20030044814, Mar 6, 2003

Filed:

Feb 8, 2002

Appl. No.:

10/071838

Inventors:

Jing Li - Flushing NY, US
Scott Powers - Greenlawn NY, US
Phil Xiang - San Francisco CA, US
Yue Peng - South Setauket NY, US

Assignee:

Tularik Inc. - South San Francisco CA

International Classification:

C12Q001/68
G01N033/574
C12P019/34

US Classification:

435/006000, 435/007230, 435/091200

Abstract:

The present invention provides nucleic acid and protein sequences for a novel protein, PRC17, and methods, reagents, and kits for diagnosing and treating cancer in a mammal, e.g., a human. This invention is based upon the discovery that the novel PRC17 is overexpressed and/or amplified in cancer. Methods to detect cancer or a propensity to develop cancer, to monitor the efficacy of a cancer treatment, and to treat cancer, by inhibiting the expression and/or activity of PRC17 in a cancer cell are included.

US Patent:

20030099985, May 29, 2003

Filed:

Aug 27, 2002

Appl. No.:

10/228263

Inventors:

Jing Li - Flushing NY, US

International Classification:

C12Q001/68
G06F019/00
G01N033/48
G01N033/50
A61K048/00

US Classification:

435/006000, 702/020000, 514/044000

Abstract:

There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing the C8FW gene, which are amplified breast and/or brain and/or colon and/or lung and/or prostate and/or ovarian cancer genes. The C8FW gene, its expressed protein products and antibodies are used diagnostically or as targets for cancer therapy or vaccine; they are also used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy.

US Patent:

20040005596, Jan 8, 2004

Filed:

Mar 18, 2003

Appl. No.:

10/390191

Inventors:

Jing Li - Flushing NY, US
Scott Powers - Greenlawn NY, US
Jianxin Yang - Commack NY, US

International Classification:

C12Q001/68
G01N033/574
C07H021/04
A61K048/00

US Classification:

435/006000, 514/044000, 536/023200, 435/007230

Abstract:

There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing the CTSZ and CD24 genes, which are amplified colon cancer and/or ovarian cancer and/or breast cancer genes. The CTSZ and CD24 genes, their expressed protein products and antibodies are used diagnostically or as targets for cancer therapy or vaccine; they also are used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy.

US Patent:

20040005615, Jan 8, 2004

Filed:

May 22, 2003

Appl. No.:

10/443108

Inventors:

Jing Li - Flushing NY, US
David Mu - Jericho NY, US
Jianxin Yang - Commack NY, US

International Classification:

C12Q001/68
C07H021/04
C12P021/02
C12N005/06
A61K048/00
C07K014/705

US Classification:

435/006000, 435/069100, 435/320100, 435/325000, 530/350000, 514/044000, 536/023500

Abstract:

There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing the RecQL5, CTXL, USP13, MCL1, and Pellino1 genes, which are amplified in many types of cancer. The RecQL5, CTXL, USP13, MCL1, and Pellino1 genes, their expressed protein products and antibodies are used diagnostically or as targets for cancer therapy or as vaccines; they also are used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy.

US Patent:

20040171037, Sep 2, 2004

Filed:

Nov 18, 2003

Appl. No.:

10/715117

Inventors:

Jing Li - Flushing NY, US
Scott Powers - Greenlawn NY, US
Wun Sin - Dix Hills NY, US
Jianxin Yang - Commack NY, US

International Classification:

C12Q001/68
A61K048/00

US Classification:

435/006000, 514/044000

Abstract:

There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing genes, which are amplified in many types of cancer. The amplified genes, their expressed protein products and antibodies are used diagnostically or as targets for cancer therapy or as vaccines; they also are used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy.

US Patent:

20100143383, Jun 10, 2010

Filed:

Oct 29, 2009

Appl. No.:

12/608069

Inventors:

Andrew D. Howard - Park Ridge NJ, US
Jing Li - Skillman NJ, US
Yun-Ping Zhou - East Brunswick NJ, US

International Classification:

A61K 39/395
C12Q 1/02
A61P 3/10

US Classification:

4241721, 435 29

Abstract:

Methods for identifying OXGR1 modulator useful for the treatment of diabetes and conditions associated with diabetes are provided. Further provided are methods for treating diabetes and conditions associated with diabetes with an OXGR1 agonist.

US Patent:

20120152175, Jun 21, 2012

Filed:

Dec 20, 2010

Appl. No.:

12/928801

Inventors:

Jing Li - Flushing NY, US

International Classification:

A01K 29/00

US Classification:

119161

Abstract:

Training pad for housebreaking young dogs consisting of absorbent material imprinted with a circle which is impregnated with scented blue ink, contains SAP in the center, and backed by water impervious polyethylene which attracts young dogs to urinate only in the circle part of the pad.